Vendor review
HK Peptides reviews
HK Peptides reviews from 466 independent lab tests (Retatrutide, Tirzepatide and GHK-Cu): grade A, purity and fill accuracy. Is HK Peptides legit? See what its vials showed.
What the lab tests show
466 tests on record, newest first. Scores are purity divided by ten.
| Date | Product | Purity | Quantity | Identity | Certificate |
|---|---|---|---|---|---|
| Oct 12, 2026 | GHK-Cu | 99.9 % | 111 mg of 100 mg (11 %) | Pass | View |
| Oct 6, 2026 | GHK-Cu | 99.7 % | 55.3 mg of 50 mg (11 %) | Pass | View |
| Oct 6, 2026 | Tirzepatide | 99.9 % | 37.1 mg of 30 mg (24 %) | Pass | View |
| Oct 3, 2026 | Retatrutide | 99.9 % | 56.8 mg of 50 mg (14 %) | Pass | View |
| Sep 30, 2026 | Ipamorelin | 99.3 % | 10.1 mg of 10 mg (1 %) | Pass | View |
| Sep 24, 2026 | GHK-Cu | 99.9 % | 51.9 mg of 50 mg (4 %) | Pass | View |
| Sep 24, 2026 | Tirzepatide | 99.8 % | 61.9 mg of 60 mg (3 %) | Pass | View |
| Sep 24, 2026 | Tirzepatide | 10 mg | Fail | View | |
| Sep 24, 2026 | Tirzepatide | 75.9 % | 45.56 mg of 60 mg (-24 %) | Pass | View |
| Sep 24, 2026 | Retatrutide | 99.9 % | 27.8 mg of 30 mg (-7 %) | Pass | View |
| Sep 24, 2026 | Tesamorelin | 99.9 % | 18.5 mg of 20 mg (-8 %) | Pass | View |
| Sep 17, 2026 | Retatrutide | 99.9 % | 8.86 mg of 10 mg (-11 %) | Pass | View |
| Sep 15, 2026 | GHK-Cu | 99.9 % | 88 mg of 100 mg (-12 %) | Pass | View |
| Sep 14, 2026 | Retatrutide | 99.8 % | 33.6 mg of 30 mg (12 %) | Pass | View |
| Sep 10, 2026 | TB-500 | 98 % | 9.63 mg of 10 mg (-4 %) | Pass | View |
| Sep 9, 2026 | Retatrutide | 99.9 % | 28.4 mg of 30 mg (-5 %) | Pass | View |
| Sep 9, 2026 | Retatrutide | 10 mg | Fail | View | |
| Sep 9, 2026 | BPC-157 | 99.9 % | 9.79 mg of 10 mg (-2 %) | Pass | View |
| Sep 4, 2026 | Sermorelin | 10 mg | Fail | View | |
| Aug 28, 2026 | Tirzepatide | 60 mg | Fail | View | |
| Aug 28, 2026 | Tirzepatide | 20 mg | Fail | View | |
| Aug 28, 2026 | Tirzepatide | 30 mg | Fail | View | |
| Aug 28, 2026 | Tirzepatide | 40 mg | Fail | View | |
| Aug 28, 2026 | Cagrilintide | 5 mg | Fail | View | |
| Aug 26, 2026 | Retatrutide | 99.9 % | 20.4 mg of 20 mg (2 %) | Pass | View |
| Aug 13, 2026 | Retatrutide | 99.9 % | 9.79 mg of 10 mg (-2 %) | Pass | View |
| Aug 12, 2026 | Retatrutide | 99.9 % | 18.9 mg of 20 mg (-6 %) | Pass | View |
| Aug 9, 2026 | Tirzepatide | 99.8 % | 66.2 mg of 60 mg (10 %) | Pass | View |
| Aug 3, 2026 | Retatrutide | 99.9 % | 13.5 mg of 15 mg (-10 %) | Pass | View |
| Aug 3, 2026 | GHK-Cu | 99.9 % | 95.5 mg of 100 mg (-5 %) | Pass | View |
| Aug 3, 2026 | GHK-Cu | 99.9 % | 103 mg of 100 mg (3 %) | Pass | View |
| Aug 3, 2026 | Tirzepatide | 99.6 % | 13.1 mg of 15 mg (-13 %) | Pass | View |
| Jul 20, 2026 | Retatrutide | 99.9 % | 53 mg of 50 mg (6 %) | Pass | View |
| Jul 20, 2026 | GHK-Cu | 99.7 % | 68.8 mg of 50 mg (38 %) | Pass | View |
| Jul 20, 2026 | Cagrilintide | 99.7 % | 6.1 mg of 5 mg (22 %) | Pass | View |
| Jul 13, 2026 | Retatrutide | 99.9 % | 30.7 mg of 30 mg (2 %) | Pass | View |
| Jul 13, 2026 | Cagrilintide | 99.9 % | 4.88 mg of 5 mg (-2 %) | Pass | View |
| Jul 9, 2026 | Tirzepatide | 99.9 % | 79.7 mg of 70 mg (14 %) | Pass | View |
| Jul 9, 2026 | Melanotan II | 99.9 % | 11.8 mg of 10 mg (18 %) | Pass | View |
| Jun 22, 2026 | Retatrutide | 99.9 % | 11.3 mg of 10 mg (13 %) | Pass | View |
| Jun 16, 2026 | Retatrutide | 99.8 % | 20.5 mg of 20 mg (2 %) | Pass | View |
| Jun 12, 2026 | Retatrutide | 99.9 % | 9.44 mg of 10 mg (-6 %) | Pass | View |
| Jun 12, 2026 | BPC-157 | 99.9 % | 5.39 mg of 5 mg (8 %) | Pass | View |
| Jun 12, 2026 | TB-500 | 99.9 % | 4.73 mg of 5 mg (-5 %) | Pass | View |
| Jun 12, 2026 | Tesamorelin | 10 mg | Fail | View | |
| Jun 8, 2026 | Tirzepatide | 99.1 % | 16.8 mg of 30 mg (-44 %) | Pass | View |
| Jun 1, 2026 | Semaglutide | 99.9 % | 5.05 mg of 5 mg (1 %) | Pass | View |
| May 19, 2026 | Tirzepatide | 99.9 % | 80.1 mg of 60 mg (34 %) | Pass | View |
| May 8, 2026 | Retatrutide | 99.9 % | 10.1 mg of 10 mg (1 %) | Pass | View |
| May 8, 2026 | Retatrutide | 99.9 % | 14.3 mg of 15 mg (-5 %) | Pass | View |
| May 8, 2026 | Retatrutide | 99.9 % | 5.03 mg of 5 mg (1 %) | Pass | View |
| May 8, 2026 | Tirzepatide | 99.9 % | 14.5 mg of 15 mg (-3 %) | Pass | View |
| May 6, 2026 | Retatrutide | 99.9 % | 19.8 mg of 20 mg (-1 %) | Pass | View |
| May 6, 2026 | Tirzepatide | 20 mg | Fail | View | |
| May 5, 2026 | Retatrutide | 99.9 % | 10.2 mg of 10 mg (2 %) | Pass | View |
| May 5, 2026 | GHK-Cu | 99.7 % | 52.8 mg of 50 mg (6 %) | Pass | View |
| May 5, 2026 | GHK-Cu | 99.9 % | 126 mg of 100 mg (26 %) | Pass | View |
| May 5, 2026 | Tesamorelin | 99.9 % | 5 mg of 5 mg (0 %) | Pass | View |
| May 5, 2026 | GHK-Cu | 99.9 % | 59.2 mg of 50 mg (18 %) | Pass | View |
| May 5, 2026 | Semaglutide | 99.9 % | 4.79 mg of 10 mg (-52 %) | Pass | View |
What HK Peptides sells
No current listings on record.
About HK Peptides
Finnrick has tested 466 samples from HK Peptides across 13 products.